Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -41.49% | -57.47% | -39.64% | -39.56% | -53.40% |
| Total Other Revenue | -1.57% | 3.42% | -19.46% | 4.20% | -28.25% |
| Total Revenue | -39.93% | -56.07% | -39.05% | -38.35% | -52.75% |
| Cost of Revenue | -33.41% | -28.50% | -35.89% | -33.96% | -37.02% |
| Gross Profit | 25.80% | -71.57% | 30.87% | 27.73% | -3.01% |
| SG&A Expenses | -13.29% | -17.94% | -26.13% | -26.75% | -24.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.12% | -26.74% | -34.42% | -32.90% | -35.23% |
| Operating Income | 22.08% | -28.59% | 29.39% | 27.44% | 6.94% |
| Income Before Tax | 23.26% | -34.00% | 32.02% | 29.07% | 8.50% |
| Income Tax Expenses | 217.39% | 71.32% | -102.74% | -104.20% | -105.96% |
| Earnings from Continuing Operations | 20.75% | -40.11% | 50.52% | 43.75% | 24.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.75% | -40.11% | 50.52% | 43.75% | 24.46% |
| EBIT | 22.08% | -28.59% | 29.39% | 27.44% | 6.94% |
| EBITDA | 23.88% | -37.81% | 25.37% | 22.43% | -3.81% |
| EPS Basic | 21.76% | -38.95% | 51.08% | 44.29% | 25.00% |
| Normalized Basic EPS | 23.18% | -36.35% | 31.77% | 29.98% | 8.80% |
| EPS Diluted | 21.82% | -38.25% | 51.13% | 44.36% | 25.21% |
| Normalized Diluted EPS | 23.20% | -36.10% | 31.79% | 30.00% | 8.55% |
| Average Basic Shares Outstanding | 1.30% | 1.11% | 1.05% | 0.98% | 0.46% |
| Average Diluted Shares Outstanding | 0.39% | -0.71% | 1.04% | 0.97% | -0.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |